<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
	xmlns:media="http://search.yahoo.com/mrss/"
>

<channel>
	<title>Pharma Exec Blog &#187; announcements</title>
	<atom:link href="http://blog.pharmexec.com/tag/announcements/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.pharmexec.com</link>
	<description>The Business of Pharmaceuticals</description>
	<lastBuildDate>Wed, 08 Feb 2012 16:14:43 +0000</lastBuildDate>
	
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<!-- podcast_generator="podPress/8.8" -->
		<copyright>&#xA9;Advanstar Communications </copyright>
		<managingEditor>gkoroneos@advanstar.com (Advanstar Communications)</managingEditor>
		<webMaster>gkoroneos@advanstar.com(Advanstar Communications)</webMaster>
		<category>Pharmceuticals</category>
		<ttl>1440</ttl>
		<itunes:keywords>pharma, pharmaceuticals, life science, business, news, pharmexec, unplugged</itunes:keywords>
		<itunes:subtitle></itunes:subtitle>
		<itunes:summary>The Business of Pharmaceuticals</itunes:summary>
		<itunes:author>Advanstar Communications</itunes:author>
		<itunes:category text="Science &amp; Medicine">
  <itunes:category text="Medicine"/>
</itunes:category>
<itunes:category text="Science &amp; Medicine">
  <itunes:category text="Medicine"/>
</itunes:category>
<itunes:category text="Business">
  <itunes:category text="Management &amp; Marketing"/>
</itunes:category>
		<itunes:owner>
			<itunes:name>Advanstar Communications</itunes:name>
			<itunes:email>gkoroneos@advanstar.com</itunes:email>
		</itunes:owner>
		<itunes:block>No</itunes:block>
		<itunes:explicit>no</itunes:explicit>
		<itunes:image href="http://lifeinabungalo.com/art/pharmaunplugged_300x30.jpg" />
		<image>
			<url>http://lifeinabungalo.com/art/pharmaunplugged_300x30.jpg</url>
			<title>Pharma Exec Blog</title>
			<link>http://blog.pharmexec.com</link>
			<width>144</width>
			<height>144</height>
		</image>
		<item>
		<title>Moving On + Up</title>
		<link>http://blog.pharmexec.com/2008/09/26/moving-on-up/</link>
		<comments>http://blog.pharmexec.com/2008/09/26/moving-on-up/#comments</comments>
		<pubDate>Fri, 26 Sep 2008 14:53:57 +0000</pubDate>
		<dc:creator>Brittany Agro</dc:creator>
				<category><![CDATA[People]]></category>
		<category><![CDATA[announcements]]></category>
		<category><![CDATA[business]]></category>
		<category><![CDATA[communications]]></category>
		<category><![CDATA[Encorium]]></category>
		<category><![CDATA[executives]]></category>
		<category><![CDATA[Ferring]]></category>
		<category><![CDATA[Genesis]]></category>
		<category><![CDATA[GlaxoSmithKline]]></category>
		<category><![CDATA[Lilly]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[Merz]]></category>
		<category><![CDATA[new hires]]></category>
		<category><![CDATA[pharmaceutical industry]]></category>
		<category><![CDATA[promotions]]></category>
		<category><![CDATA[Questcor]]></category>
		<category><![CDATA[Sanofi-Aventis]]></category>
		<category><![CDATA[Wyeth]]></category>
		<category><![CDATA[Zafgen]]></category>
		<category><![CDATA[Zosano]]></category>

		<guid isPermaLink="false">http://blog.pharmexec.com/?p=224</guid>
		<description><![CDATA[ 
Promotions and hires for September 26, 2008:

Merck named Barry J. Goldstein, M.D., vice president of clinical development for diabetes and obesity


Sanofi-Aventis announced that Chris Viehbacher will succeed current CEO Gerard Le Fur in December


GlaxoSmithKline named Ellen Strahlman chief medical officer


Questcor Pharmaceuticals appointed Gary Sawka CFO


Encorium appointed David Ginsberg president and CEO


Wyeth named Daniel J. [...]]]></description>
			<content:encoded><![CDATA[<p style="padding-left: 0px; text-align: center;"><a href="http://blog.pharmexec.com/wp-content/uploads/goldstein_barry4.jpg"><img class="size-thumbnail wp-image-249 aligncenter" title="Barry Goldstein" src="http://blog.pharmexec.com/wp-content/uploads/goldstein_barry4.jpg" alt="Barry Goldstein" width="108" height="151" /> </a><a href="http://blog.pharmexec.com/wp-content/uploads/thomas_hughes1.jpg"><img class="aligncenter size-thumbnail wp-image-251" title="Thomas Hughes" src="http://blog.pharmexec.com/wp-content/uploads/thomas_hughes1.jpg" alt="Thomas Hughes" width="108" height="151" /></a><a href="http://blog.pharmexec.com/wp-content/uploads/mcintyre_dan2.jpg"><img class="aligncenter size-medium wp-image-262" title="Dan McIntyre" src="http://blog.pharmexec.com/wp-content/uploads/mcintyre_dan2.jpg" alt="Dan McIntyre" width="100" height="151" /></a></p>
<p style="padding-left: 0px; text-align: left;">Promotions and hires for September 26, 2008:</p>
<ul>
<li>Merck named <strong>Barry J. Goldstein</strong>, M.D., vice president of clinical development for diabetes and obesity</li>
</ul>
<ul>
<li>Sanofi-Aventis announced that<strong> Chris Viehbacher </strong>will succeed current CEO Gerard Le Fur in December</li>
</ul>
<ul>
<li>GlaxoSmithKline named <strong>Ellen Strahlman</strong> chief medical officer</li>
</ul>
<ul>
<li>Questcor Pharmaceuticals appointed <strong>Gary Sawka</strong> CFO</li>
</ul>
<ul>
<li>Encorium appointed <strong>David Ginsberg</strong> president and CEO</li>
</ul>
<ul>
<li>Wyeth named <strong>Daniel J. McIntyre </strong>vice president, corporate communications</li>
</ul>
<ul>
<li>Genesis Pharmaceuticals appointed <strong>John Yang Wang</strong> to its board of directors</li>
</ul>
<ul>
<li>Zosano Pharma appointed <strong>Gail Schulze </strong>chair and CEO</li>
</ul>
<ul>
<li>Lilly named <strong>John Lechleiter </strong>its board of directors chairman</li>
</ul>
<ul>
<li>Merz Pharmaceuticals named<strong> Jack Britts</strong> president and CEO</li>
</ul>
<ul>
<li>Ferring Pharmaceuticals appointed <strong>Paul Korner</strong>, M.D., vice president, medical affairs</li>
</ul>
<ul>
<li>Zafgen appointed <strong>Thomas Hughes</strong> the companyâ€™s first CEO</li>
</ul>
]]></content:encoded>
			<wfw:commentRss>http://blog.pharmexec.com/2008/09/26/moving-on-up/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

